Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. (SHE:301096)
China flag China · Delayed Price · Currency is CNY
38.64
+0.86 (2.28%)
Nov 17, 2026, 4:00 PM EST

SHE:301096 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
333.92292.6428.97881.931,2392,013
Trading Asset Securities
108083---
Cash & Short-Term Investments
343.92372.6511.97881.931,2392,013
Cash Growth
-36.63%-27.22%-41.95%-28.81%-38.46%1406.49%
Accounts Receivable
981.56902744.4532.18254.49124.41
Other Receivables
14.999.763.164.14.794.1
Receivables
996.55911.77747.56536.28259.28128.5
Inventory
192.89176.44177.3493.1766.0522.85
Prepaid Expenses
----1.83-
Other Current Assets
95.2291.28108.6196.443.9461.2
Total Current Assets
1,6291,5521,5451,6081,6102,226
Property, Plant & Equipment
1,6831,7771,8321,7411,075566.63
Long-Term Investments
206.83202.5187.78136.8781.125.77
Other Intangible Assets
87.4189.893.4392.0782.3760.79
Long-Term Accounts Receivable
26.28---1.911.95
Long-Term Deferred Tax Assets
38.6536.8735.5548.4353.4122.86
Long-Term Deferred Charges
1.521.081.420.253.9914.41
Other Long-Term Assets
12.3327.0525.843.1421.626.92
Total Assets
3,6843,6863,7213,6692,9302,925

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
114.3648.7841.82130.25167.0312.64
Accrued Expenses
17.4130.9839.973.444.6954.8
Short-Term Debt
514.05510.61360.08369.32-5.01
Current Portion of Long-Term Debt
146.04169.74104.25--220.32
Current Portion of Leases
-0.620.730.388.848.8
Current Income Taxes Payable
9.69-0.035.065.736.17
Current Unearned Revenue
87.7276.06112.4274.0162.6171.17
Other Current Liabilities
2.983.12110.14193.771.893.79
Total Current Liabilities
892.16919.91769.38846.19290.7472.69
Long-Term Debt
285.63189.51244--40.44
Long-Term Leases
0.282.342.920.93-8.14
Long-Term Unearned Revenue
33.1123.7231.4840.671.45-
Long-Term Deferred Tax Liabilities
----4.320.01
Other Long-Term Liabilities
46.6761.8494.0297.17150.9785.83
Total Liabilities
1,2581,1971,142984.97447.45607.1

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
109.23109.23109.23108.92108.17108.17
Additional Paid-In Capital
2,1252,1072,1072,1272,0612,026
Retained Earnings
241.44323.09413.49498.68313.24183.98
Treasury Stock
-50-50-50-50--
Comprehensive Income & Other
-0.17-0.18-0.14-0.14--
Total Common Equity
2,4262,4892,5792,6842,4832,318
Minority Interest
0.62----0.26-0.14
Shareholders' Equity
2,4272,4892,5792,6842,4822,318
Total Liabilities & Equity
3,6843,6863,7213,6692,9302,925

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
946872.82711.99370.648.84282.7
Net Cash (Debt)
-602.07-500.22-200.02511.291,2301,730
Net Cash Growth
----58.43%-28.92%-
Net Cash Per Share
-5.28-4.59-1.864.7211.3421.34
Filing Date Shares Outstanding
108.45108.45108.45108.14108.17108.17
Total Common Shares Outstanding
108.45108.45108.45108.14108.17108.17
Working Capital
736.41632.17776.1761.591,3191,753
Book Value Per Share
22.3722.9523.7824.8222.9521.43
Tangible Book Value
2,3392,3992,4862,5922,4002,257
Tangible Book Value Per Share
21.5622.1222.9223.9722.1920.87
Buildings
-980.29863.44859.97196.19196.14
Machinery
-1,1941,079629.9642.96319.94
Construction In Progress
-66.67206.66448.82546.21104.08